BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 1283849)

  • 1. The current and future place of vinorelbine in cancer therapy.
    Cvitkovic E; Izzo J
    Drugs; 1992; 44 Suppl 4():36-45; discussion 66-9. PubMed ID: 1283849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vinorelbine: a new promising drug in Hodgkin's disease.
    Devizzi L; Santoro A; Bonfante V; Viviani S; Bonadonna G
    Leuk Lymphoma; 1996 Aug; 22(5-6):409-14. PubMed ID: 8882953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.
    Goa KL; Faulds D
    Drugs Aging; 1994 Sep; 5(3):200-34. PubMed ID: 7803948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinorelbine: a novel vinca alkaloid.
    Toso C; Lindley C
    Am J Health Syst Pharm; 1995 Jun; 52(12):1287-304; quizz 1340-1. PubMed ID: 7656116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vinorelbine. A review of its antitumour activity in lung cancer.
    Sørensen JB
    Drugs; 1992; 44 Suppl 4():60-5; discussion 66-9. PubMed ID: 1283851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vinorelbine in the treatment of non-small-cell lung cancer and breast cancer].
    Kubota K
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1301-6. PubMed ID: 10945030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Navelbine. Current and perspective aspects. International congress of Biarritz (November 1989)].
    Armand JP
    Bull Cancer; 1990; 77(8):841-5. PubMed ID: 2169931
    [No Abstract]   [Full Text] [Related]  

  • 8. A review of the antitumour activity of vinorelbine in breast cancer.
    Marty M; Extra JM; Dieras V; Giacchetti S; Ohana S; Espié M
    Drugs; 1992; 44 Suppl 4():29-35; discussion 66-9. PubMed ID: 1283848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
    Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non-small cell lung cancer: an expanded analysis.
    Le Chevalier T; Pujol JL; Douillard JY; Alberola V; Monnier A; Riviere A; Lianes P; Chomy P; Cigolari S; Besson F
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):28-33; discussion 33-4. PubMed ID: 7973766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of vinorelbine for breast cancer.
    Smith GA
    Oncology (Williston Park); 1995 Aug; 9(8):767-73; discussion 774, 776, 779. PubMed ID: 7577376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinorelbine (Navelbine) in non-small cell lung cancer: future directions.
    Crawford J
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):85-8. PubMed ID: 7526468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vinorelbine in the treatment of lymphoma.
    Rule S; Tighe M; Davies S; Johnson S
    Hematol Oncol; 1998 Sep; 16(3):101-5. PubMed ID: 10235068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vinorelbine (Navelbine)--a new agent for the treatment of non-small cell lung cancer: a summary.
    Coltman CA
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):1-3. PubMed ID: 7973763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.
    Vokes EE; Haraf DJ; Masters GA; Hoffman PC; Drinkard LC; Ferguson M; Olak J; Watson S; Golomb HM
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):48-52. PubMed ID: 8610237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
    Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vinorelbine (Navelbine)/carboplatin combination therapy: dose intensification with granulocyte colony-stimulating factor.
    Crawford J; O'Rourke MA
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):73-8. PubMed ID: 7526467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in vinca-alkaloids: Navelbine.
    Marty M; Extra JM; Espie M; Leandri S; Besenval M; Krikorian A
    Nouv Rev Fr Hematol (1978); 1989; 31(2):77-84. PubMed ID: 2671933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developments in cytotoxic chemotherapy: advances in treatment utilising vinorelbine.
    Aapro MS; Harper P; Johnson SA; Vermorken JB
    Crit Rev Oncol Hematol; 2001 Dec; 40(3):251-63. PubMed ID: 11738948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vinorelbine (Navelbine). A new semisynthetic vinca alkaloid.
    Krikorian A; Breillout F
    Onkologie; 1991 Feb; 14(1):7-12. PubMed ID: 2057177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.